 |
Unannotated Code of Maryland (Last Updated: May 16, 2014) |
 |
HEALTH OCCUPATIONS |
|
TITLE 12. PHARMACISTS AND PHARMACIES |
|
SUBTITLE 6A. THERAPY MANAGEMENT CONTRACTS |
§ 12-6A-01. Definitions
Latest version.
-
(a) In general. -- In this subtitle the following words have the meanings indicated.
(b) Group model health maintenance organization. -- "Group model health maintenance organization" has the meaning stated in § 19-713.6 of the Health - General Article.
(c) Health maintenance organization. -- "Health maintenance organization" has the meaning stated in § 19-701(g) of the Health - General Article.
(d) Institutional facility. --
(1) "Institutional facility" means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care.
(2) "Institutional facility" does not include an urgent care facility that is not part of a facility.
(e) Licensed physician. -- "Licensed physician" means an individual who is licensed to practice medicine under Title 14 of this article.
(f) Physician-pharmacist agreement. -- "Physician-pharmacist agreement" means an agreement between a licensed physician and a licensed pharmacist that is disease-state specific and specifies the protocols that may be used.
(g) Protocol. -- "Protocol" means a course of treatment predetermined by the licensed physician and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.
(h) Therapy management contract. --
(1) "Therapy management contract" means a voluntary, written arrangement that is disease-state specific signed by each party to the arrangement between:
(i) One licensed pharmacist and the licensed pharmacist's designated alternate licensed pharmacists;
(ii) One licensed physician and alternate designated licensed physicians involved directly in patient care; and
(iii) One patient receiving care from a licensed physician and a licensed pharmacist pursuant to a physician-pharmacist agreement and protocol under this subtitle.
(2) A therapy management contract shall be related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.